EPA World Congress 2022

March 22-24, 2022, Amsterdam
Events
Category:
Published on:
February 2, 2022

We are thrilled to sponsor and attend World EPA Congress 2022, Europe’s Leading Pricing, Market Access and Evidence Congress for the Biopharma Industry.

The event will feature 250 speakers, multiple streams, and over 1000 attendees from pharma, biotech, and Payers/HTA’s. The 2022 edition will now take place over three days with expanded content on RWE, HTA, Medical Devices, Affordability, Digital Health, Analytics and Emerging Markets. The event’s core topic areas will include Market Access and Pricing, Rare Diseases, HTA/Payer, and Evidence and will cover the latest trends in reimbursement, payment models, affordability, HEOR, and many other developments within the industry.

As part of the event, our very own Andrea Mantovani, Vice President, Global Market Access will also host a roundtable “Next Generation Therapies: Access, Pricing and Ethical Issues in Perspective”.

Our attendees:

 

Related news

Blog April 17, 2023
Reimbursement of Rare Disease Drugs in Italy: Challenges and Hopes for the Future
When it comes to rare diseases, Italy has done a good job in bringing EMA-approved drugs, including orphan drugs, to the Italian market. But  multiple challenges exist, many of which(...)
Italy Market Access Pharma Rare Disease Real-World Evidence (RWE)
Blog April 17, 2023
Pharmaceutical Market Access in the UK: A Changing Landscape
Start reading this interview with Rachel Fyson to gain insight into the changing landscape of market access in the United Kingdom.
Market Access Pharma UK
Blog April 14, 2023
Lifecycle Optimization: The Path to Commercial Success
Pharmaceutical and biotech companies constantly focus on product innovation. But how can you also increase your effectiveness in order to be as commercially competitive and efficient as possible?
Market Access MedTech Pharma
News April 5, 2023
Alira Health Joins EMIG to Advance Market Access in the UK
We are pleased to announce that Alira Health has joined the Ethical Medicines Industry Group (EMIG), a multi-stakeholder network and trade association that represents the interests(...)
Market Access Patient Centricity UK
Blog March 20, 2023
The State of Market Access in Italy 2023
To learn about the state of market access in Italy today, we spoke with Giovanni Firenze, Director of Market Access Italy for Alira Health, who attended the recent 2023 Conferenza Nazionale(...)
Drug Development Italy Market Access Pharma
Events March 6, 2023
World EPA Congress 2023
We are pleased to share that we will be participating in World EPA Congress 2023 as speakers and sponsors. World Evidence, Pricing and Access Congress is Europe’s largest congress(...)
Biotech Market Access Pharma Real-World Evidence (RWE)
Blog March 6, 2023
Market Access in Catalonia: 2022 Trends and What’s Next
Alira Health contributed to the recently published 2022 BioRegion Report, the most extensive analysis of the assets, achievements, and trends in the life sciences and healthcare sector(...)
Biotech Market Access MedTech Spain
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.